Position in GRAL
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$1,437,271
-$919,278 QoQ
Shares Held
27,811
+1.0% QoQ
Ownership
0.065%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2024
8 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in GRAL Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026VAN ECK ASSOCIATES CORP holds $775,697,583 across 19 Diagnostics & Research names. GRAL ranks #13 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | DHR |
Danaher Corp /De/
|
1,629,196 | $308,895,561 | |
| 2 | A |
Agilent Technologies, Inc.
|
1,718,034 | $195,821,514 | |
| 3 | TMO |
Thermo Fisher Scientific Inc.
|
345,752 | $169,947,479 | |
| 4 | IQV |
Iqvia Holdings Inc.
|
115,799 | $19,748,360 | |
| 5 | NTRA |
Natera, Inc.
|
84,042 | $16,807,559 | |
| 6 | IDXX |
Idexx Laboratories Inc /De
|
26,710 | $15,008,081 | |
| 7 | ILMN |
Illumina, Inc.
|
113,475 | $13,986,927 | |
| 8 | MEDP |
Medpace Holdings, Inc.
|
24,759 | $11,889,024 |
All Filings in GRAL
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,437,271 | 27,811 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $2,356,549 | 27,533 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $1,583,087 | 26,773 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $1,362,886 | 26,505 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $675,966 | 26,467 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $474,952 | 26,608 | Shares | Sole | 2025-01-29 | |
| 2024-09-30 | $6,893 | 501 | Shares | Defined | 2024-10-29 | |
| 2024-06-30 | $391,704 | 25,485 | Shares | Defined | 2024-07-31 | |
| No filing history on record for this holder in this stock. | ||||||